These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Diverse roles of TGF-β receptor II in renal fibrosis and inflammation in vivo and in vitro. Meng XM, Huang XR, Xiao J, Chen HY, Zhong X, Chung AC, Lan HY. J Pathol; 2012 Jun; 227(2):175-88. PubMed ID: 22190171 [Abstract] [Full Text] [Related]
3. LSKL, a peptide antagonist of thrombospondin-1, attenuates renal interstitial fibrosis in rats with unilateral ureteral obstruction. Xie XS, Li FY, Liu HC, Deng Y, Li Z, Fan JM. Arch Pharm Res; 2010 Feb; 33(2):275-84. PubMed ID: 20195829 [Abstract] [Full Text] [Related]
9. Ginsenoside Rg1 modulation on thrombospondin-1 and vascular endothelial growth factor expression in early renal fibrogenesis in unilateral obstruction. Xie XS, Liu HC, Wang FP, Zhang CL, Zuo C, Deng Y, Fan JM. Phytother Res; 2010 Nov; 24(11):1581-7. PubMed ID: 21031612 [Abstract] [Full Text] [Related]
10. CD44v3-v10 reduces the profibrotic effects of TGF-β1 and attenuates tubular injury in the early stage of chronic obstructive nephropathy. Rampanelli E, Rouschop K, Teske GJ, Claessen N, Leemans JC, Florquin S. Am J Physiol Renal Physiol; 2013 Nov 15; 305(10):F1445-54. PubMed ID: 24026183 [Abstract] [Full Text] [Related]